ID SCG3_HUMAN Reviewed; 468 AA. AC Q8WXD2; A8K2B0; B3KQP6; B4DK99; F5H3R8; Q96C83; Q96GE8; Q9Y6G7; DT 19-SEP-2002, integrated into UniProtKB/Swiss-Prot. DT 13-APR-2004, sequence version 3. DT 27-MAR-2024, entry version 172. DE RecName: Full=Secretogranin-3; DE AltName: Full=Secretogranin III; DE Short=SgIII; DE Flags: Precursor; GN Name=SCG3; ORFNames=UNQ2502/PRO5990; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Pituitary; RA Song H., Peng Y., Huang Q., Dai M., Mao Y., Zhang Q., Mao M., Fu G., RA Luo M., Chen J., Hu R.; RT "Human secretogranin III mRNA, complete cds."; RL Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND SUBCELLULAR RP LOCATION. RX PubMed=12098761; RA Rong Y.P., Liu F., Zeng L.C., Ma W.J., Wei D.Z., Han Z.G.; RT "Cloning and characterization of a novel human secretory protein: RT secretogranin III."; RL Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 34:411-417(2002). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., RA Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., RA Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., RA Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., RA Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., RA Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale effort to RT identify novel human secreted and transmembrane proteins: a bioinformatics RT assessment."; RL Genome Res. 13:2265-2270(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Retinoblastoma, and Thalamus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16572171; DOI=10.1038/nature04601; RA Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K., RA Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K., RA FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N., RA Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S., RA Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K., RA DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J., RA Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E., RA Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B., RA Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R., RA O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B., RA Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S., RA Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.; RT "Analysis of the DNA sequence and duplication history of human chromosome RT 15."; RL Nature 440:671-675(2006). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ALA-167. RC TISSUE=Brain, and Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP POLYMORPHISM. RX PubMed=17200173; DOI=10.1210/jc.2006-1808; RA Tanabe A., Yanagiya T., Iida A., Saito S., Sekine A., Takahashi A., RA Nakamura T., Tsunoda T., Kamohara S., Nakata Y., Kotani K., Komatsu R., RA Itoh N., Mineo I., Wada J., Funahashi T., Miyazaki S., Tokunaga K., RA Hamaguchi K., Shimada T., Tanaka K., Yamada K., Hanafusa T., Oikawa S., RA Yoshimatsu H., Sakata T., Matsuzawa Y., Kamatani N., Nakamura Y., Hotta K.; RT "Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) RT gene that form secretory granules with appetite-related neuropeptides are RT associated with obesity."; RL J. Clin. Endocrinol. Metab. 92:1145-1154(2007). RN [9] RP INTERACTION WITH SCG2, AND FUNCTION. RX PubMed=19357184; DOI=10.1677/joe-08-0531; RA Hotta K., Hosaka M., Tanabe A., Takeuchi T.; RT "Secretogranin II binds to secretogranin III and forms secretory granules RT with orexin, neuropeptide Y, and POMC."; RL J. Endocrinol. 202:111-121(2009). RN [10] RP GLYCOSYLATION AT THR-216; THR-231 AND SER-359, AND IDENTIFICATION BY MASS RP SPECTROMETRY. RX PubMed=23234360; DOI=10.1021/pr300963h; RA Halim A., Ruetschi U., Larson G., Nilsson J.; RT "LC-MS/MS characterization of O-glycosylation sites and glycan structures RT of human cerebrospinal fluid glycoproteins."; RL J. Proteome Res. 12:573-584(2013). RN [11] RP SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND GLYCOSYLATION AT SER-37. RX PubMed=25326458; DOI=10.1074/mcp.m114.043703; RA Noborn F., Gomez Toledo A., Sihlbom C., Lengqvist J., Fries E., Kjellen L., RA Nilsson J., Larson G.; RT "Identification of chondroitin sulfate linkage region glycopeptides reveals RT prohormones as a novel class of proteoglycans."; RL Mol. Cell. Proteomics 14:41-49(2015). RN [12] RP FUNCTION. RX PubMed=29154827; DOI=10.1016/j.bbrc.2017.11.080; RA Tang F., Pacheco M.T.F., Chen P., Liang D., Li W.; RT "Secretogranin III promotes angiogenesis through MEK/ERK signaling RT pathway."; RL Biochem. Biophys. Res. Commun. 495:781-786(2018). CC -!- FUNCTION: Member of the granin protein family that regulates the CC biogenesis of secretory granules (PubMed:19357184). Acts as a sorting CC receptor for intragranular proteins including chromogranin A/CHGA (By CC similarity). May also play a role in angiogenesis. Promotes endothelial CC proliferation, migration and tube formation through MEK/ERK signaling CC pathway (PubMed:29154827). {ECO:0000250|UniProtKB:P47868, CC ECO:0000269|PubMed:19357184, ECO:0000269|PubMed:29154827}. CC -!- SUBUNIT: Interacts with CHGA (PubMed:19357184) (By similarity). CC Interacts with secretogranin II/SCG2 (PubMed:19357184). Interacts (via CC C-terminus) with CPE (By similarity). {ECO:0000250|UniProtKB:P47867, CC ECO:0000269|PubMed:19357184}. CC -!- INTERACTION: CC Q8WXD2; O00560: SDCBP; NbExp=3; IntAct=EBI-12162999, EBI-727004; CC -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle CC {ECO:0000250|UniProtKB:P47868}. Cytoplasmic vesicle, secretory vesicle CC membrane {ECO:0000250|UniProtKB:P47868}; Peripheral membrane protein CC {ECO:0000250}. Secreted {ECO:0000269|PubMed:12098761, CC ECO:0000269|PubMed:25326458}. Note=Associated with the secretory CC granule membrane through direct binding to cholesterol-enriched lipid CC rafts. {ECO:0000250|UniProtKB:P47868}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8WXD2-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8WXD2-2; Sequence=VSP_042876; CC -!- TISSUE SPECIFICITY: Detected in urine (at protein level) CC (PubMed:25326458). Expressed in brain, heart, kidney, liver and CC skeletal muscle. {ECO:0000269|PubMed:12098761, CC ECO:0000269|PubMed:25326458}. CC -!- PTM: O-glycosylated. {ECO:0000269|PubMed:23234360, CC ECO:0000269|PubMed:25326458}. CC -!- POLYMORPHISM: Polymorphisms in the 5'-flanking region and in intron 1 CC may have an effect on transcriptional activity and be associated with CC an increase in subcutaneous, but not visceral, fat area. Hence, may CC influence the risk of obesity. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF078851; AAD44483.1; -; mRNA. DR EMBL; AF453583; AAL67431.1; -; mRNA. DR EMBL; AY359093; AAQ89451.1; -; mRNA. DR EMBL; AK075314; BAG52108.1; -; mRNA. DR EMBL; AK290175; BAF82864.1; -; mRNA. DR EMBL; AK296466; BAG59111.1; -; mRNA. DR EMBL; AC020892; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471082; EAW77426.1; -; Genomic_DNA. DR EMBL; BC009511; AAH09511.2; -; mRNA. DR EMBL; BC014539; AAH14539.1; -; mRNA. DR CCDS; CCDS10142.1; -. [Q8WXD2-1] DR CCDS; CCDS53947.1; -. [Q8WXD2-2] DR RefSeq; NP_001158729.1; NM_001165257.1. [Q8WXD2-2] DR RefSeq; NP_037375.2; NM_013243.3. [Q8WXD2-1] DR AlphaFoldDB; Q8WXD2; -. DR BioGRID; 118874; 10. DR DIP; DIP-29451N; -. DR IntAct; Q8WXD2; 10. DR STRING; 9606.ENSP00000220478; -. DR GlyConnect; 732; 13 N-Linked glycans (1 site), 1 O-Linked glycan (3 sites). DR GlyCosmos; Q8WXD2; 5 sites, 16 glycans. DR GlyGen; Q8WXD2; 8 sites, 14 N-linked glycans (2 sites), 3 O-linked glycans (5 sites). DR iPTMnet; Q8WXD2; -. DR PhosphoSitePlus; Q8WXD2; -. DR BioMuta; SCG3; -. DR DMDM; 46397796; -. DR EPD; Q8WXD2; -. DR jPOST; Q8WXD2; -. DR MassIVE; Q8WXD2; -. DR PaxDb; 9606-ENSP00000220478; -. DR PeptideAtlas; Q8WXD2; -. DR ProteomicsDB; 75012; -. [Q8WXD2-1] DR ProteomicsDB; 75013; -. [Q8WXD2-2] DR Antibodypedia; 1520; 314 antibodies from 31 providers. DR DNASU; 29106; -. DR Ensembl; ENST00000220478.8; ENSP00000220478.3; ENSG00000104112.9. [Q8WXD2-1] DR Ensembl; ENST00000542355.6; ENSP00000445205.2; ENSG00000104112.9. [Q8WXD2-2] DR GeneID; 29106; -. DR KEGG; hsa:29106; -. DR MANE-Select; ENST00000220478.8; ENSP00000220478.3; NM_013243.4; NP_037375.2. DR UCSC; uc002abh.4; human. [Q8WXD2-1] DR AGR; HGNC:13707; -. DR CTD; 29106; -. DR DisGeNET; 29106; -. DR GeneCards; SCG3; -. DR HGNC; HGNC:13707; SCG3. DR HPA; ENSG00000104112; Tissue enhanced (brain, pituitary gland, retina). DR MIM; 611796; gene. DR neXtProt; NX_Q8WXD2; -. DR OpenTargets; ENSG00000104112; -. DR PharmGKB; PA34988; -. DR VEuPathDB; HostDB:ENSG00000104112; -. DR eggNOG; ENOG502QUJH; Eukaryota. DR GeneTree; ENSGT00390000005488; -. DR HOGENOM; CLU_031198_1_0_1; -. DR InParanoid; Q8WXD2; -. DR OMA; TDKAIHN; -. DR OrthoDB; 5353945at2759; -. DR PhylomeDB; Q8WXD2; -. DR TreeFam; TF331266; -. DR PathwayCommons; Q8WXD2; -. DR Reactome; R-HSA-114608; Platelet degranulation. DR Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs). DR Reactome; R-HSA-8957275; Post-translational protein phosphorylation. DR SignaLink; Q8WXD2; -. DR BioGRID-ORCS; 29106; 14 hits in 1153 CRISPR screens. DR ChiTaRS; SCG3; human. DR GeneWiki; SCG3; -. DR GenomeRNAi; 29106; -. DR Pharos; Q8WXD2; Tbio. DR PRO; PR:Q8WXD2; -. DR Proteomes; UP000005640; Chromosome 15. DR RNAct; Q8WXD2; Protein. DR Bgee; ENSG00000104112; Expressed in islet of Langerhans and 119 other cell types or tissues. DR ExpressionAtlas; Q8WXD2; baseline and differential. DR GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0034774; C:secretory granule lumen; TAS:Reactome. DR GO; GO:0030667; C:secretory granule membrane; IBA:GO_Central. DR GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell. DR GO; GO:0003723; F:RNA binding; HDA:UniProtKB. DR GO; GO:0033366; P:protein localization to secretory granule; IBA:GO_Central. DR InterPro; IPR026197; SCG3. DR PANTHER; PTHR17388; SECRETOGRANIN III; 1. DR PANTHER; PTHR17388:SF2; SECRETOGRANIN-3; 1. DR Pfam; PF15467; SGIII; 1. DR Genevisible; Q8WXD2; HS. PE 1: Evidence at protein level; KW Alternative splicing; Cleavage on pair of basic residues; KW Cytoplasmic vesicle; Glycoprotein; Membrane; Phosphoprotein; Proteoglycan; KW Reference proteome; Secreted; Signal. FT SIGNAL 1..19 FT /evidence="ECO:0000255" FT CHAIN 20..468 FT /note="Secretogranin-3" FT /id="PRO_0000005461" FT REGION 23..69 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 353..406 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 28..59 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 358..406 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 37 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P47867" FT MOD_RES 362 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P47867" FT CARBOHYD 37 FT /note="O-linked (Xyl...) (chondroitin sulfate) serine" FT /evidence="ECO:0000269|PubMed:25326458" FT CARBOHYD 216 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000269|PubMed:23234360" FT CARBOHYD 231 FT /note="O-linked (GalNAc...) threonine" FT /evidence="ECO:0000269|PubMed:23234360" FT CARBOHYD 359 FT /note="O-linked (GalNAc...) serine" FT /evidence="ECO:0000269|PubMed:23234360" FT VAR_SEQ 1..232 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_042876" FT VARIANT 125 FT /note="S -> N (in dbSNP:rs2305710)" FT /id="VAR_013827" FT VARIANT 167 FT /note="V -> A (in dbSNP:rs17851186)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_067273" FT VARIANT 233 FT /note="M -> V (in dbSNP:rs35664837)" FT /id="VAR_034484" FT CONFLICT 79 FT /note="K -> R (in Ref. 1; AAD44483)" FT /evidence="ECO:0000305" FT CONFLICT 150 FT /note="D -> G (in Ref. 4; BAG52108)" FT /evidence="ECO:0000305" FT CONFLICT 272..274 FT /note="EEL -> RDF (in Ref. 1; AAD44483)" FT /evidence="ECO:0000305" FT CONFLICT 421 FT /note="K -> R (in Ref. 4; BAG59111)" FT /evidence="ECO:0000305" SQ SEQUENCE 468 AA; 53005 MW; 5E6BBDDFFF3B8D82 CRC64; MGFLGTGTWI LVLVLPIQAF PKPGGSQDKS LHNRELSAER PLNEQIAEAE EDKIKKTYPP ENKPGQSNYS FVDNLNLLKA ITEKEKIEKE RQSIRSSPLD NKLNVEDVDS TKNRKLIDDY DSTKSGLDHK FQDDPDGLHQ LDGTPLTAED IVHKIAARIY EENDRAVFDK IVSKLLNLGL ITESQAHTLE DEVAEVLQKL ISKEANNYEE DPNKPTSWTE NQAGKIPEKV TPMAAIQDGL AKGENDETVS NTLTLTNGLE RRTKTYSEDN FEELQYFPNF YALLKSIDSE KEAKEKETLI TIMKTLIDFV KMMVKYGTIS PEEGVSYLEN LDEMIALQTK NKLEKNATDN ISKLFPAPSE KSHEETDSTK EEAAKMEKEY GSLKDSTKDD NSNPGGKTDE PKGKTEAYLE AIRKNIEWLK KHDKKGNKED YDLSKMRDFI NKQADAYVEK GILDKEEAEA IKRIYSSL //